| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |